Robotics Engineering Poised to Enter the Human Heart
What changes would occur in the treatment of dangerous diseases if medication could be delivered directly to the site of infection in the heart, rather than spreading throughout the body? Researchers are working to find a new way to deliver drugs to hard-to-reach heart tissues using very small robots.
Will the era of high-risk surgeries end? From routine drug delivery to precise targeting of dangerous infections
If the drug could be delivered directly to the site of infection in the heart, instead of being spread throughout the body, how would it change the treatment of dangerous diseases? Researchers are trying to find a new way to deliver drugs to hard-to-reach tissues of the heart with the help of very small robots.
Ambassador Arjan-Yekta Farahani: The heart beats dozens of times every minute and delivers blood throughout the body; This feature makes the accurate delivery of the drug to some points a complicated issue. In dangerous heart infections, especially valve infections, treatment may be long and in some cases require surgical intervention. Now, engineers and medical researchers are looking for a way to deliver the drug to the site of infection in a more targeted manner; An idea formed from the combination of robotics engineering, medical imaging and advanced drug delivery. But can these small robots really change the course of treatment or are we still far from using them in hospitals?
Small robots, a big issue in medical science
In the field of medical robotics, Johns Hopkins engineers are working on miniature systems that aim to help deliver drugs to specific areas of the body. The importance of such an approach is that the treatment is not limited to choosing the right drug; Sometimes, getting a sufficient amount of medicine to the right place is also a major challenge.
In heart infections, including endocarditis, microbes can accumulate on the heart valves and form structures called infective masses, according to Johns Hopkins University. The treatment of this disease usually requires appropriate antibiotics and sometimes surgery; Therefore, any technology that can help better access the drug to the site of infection is worth investigating. Read more:
Super sale and pre-sale of a Saipa product; How to register, price and delivery time
When does microbial resistance become fatal? How to prevent?
In conventional methods, the drug enters the bloodstream and is distributed to different parts of the body. This method is necessary and effective for many diseases, but it does not always mean that the drug reaches the highest possible concentration in the desired location.
In the future, targeted drug delivery can help doctors control the amount and location of the drug's effect more precisely. However, such a result depends on the design of the system, the type of drug, the conditions of blood flow and the characteristics of the patient's tissue, and it cannot be considered the same for all diseases.
Are these robots ready to enter the hospital?
Here, a difference must be made between the research idea and the actual treatment. Designing a small robot or demonstrating its ability in a laboratory environment alone does not prove that this technology will be safe and effective in the human heart. Researchers should examine the control of movement, biocompatibility, the possibility of clot formation, the method of exit or disintegration of the system and its possible complications.
It should also be determined what real advantage this technology has compared to existing antibiotics and whether it can help reduce complications or shorten treatment.
From robotic engineering to precision medicine
The move toward targeted therapies is part of a broader trend toward precision medicine; An approach that tries to coordinate the treatment with the characteristics of the disease and the body of each person. In the future, combining miniature robotics with imaging and intelligent drug delivery systems may enable more precise interventions.
However, to turn this idea into a usable treatment method, laboratory evidence and then valid clinical studies are necessary.